![](/img/cover-not-exists.png)
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)
L. Beex, C. Rose, H. Mouridsen, J. Jassem, M. Nooij, J. Estape, R. Paridaens, M. Piccart, T. Gorlia, S. Lardenoije, L. BailaVolume:
42
Year:
2006
Language:
english
Pages:
3186
DOI:
10.1016/j.ejca.2006.08.020
File:
PDF, 230 KB
english, 2006